Penn Immunologist to Co-direct $12 Million Grant to Study Hepatitis

John Wherry, PhD, an associate professor of Microbiology in the Perelman School of Medicine at the University of Pennsylvania, and colleagues from Massachusetts General Hospital (MGH) are co-directing a $12 million grant to study immune responses in people who have been effectively cured of hepatitis C viral infection with new, high-potency antiviral drugs.

Karen Kreeger

Penn Study Describes New Models for Testing Parkinson's Disease Immune-based Drugs

Using powerful, newly developed cell culture and mouse  models of sporadic Parkinson’s disease (PD), a team of researchers from the Perelman School of Medicine at the University of Pennsylvania, has demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain.

Karen Kreeger

Penn Yeast Study Identifies Novel Longevity Pathway

Ancient philosophers looked to alchemy for clues to life everlasting. Today, researchers look to their yeast. These single-celled microbes have long served as model systems for the puzzle that is the aging process, and in this week’s issue of Cell Metabolism, they fill in yet another piece.

Karen Kreeger